Cosmo Bio Company,Limited engages in the manufacture, marketing, sale, import, and export of life science research biotools worldwide. The company distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as detection reagents, cell and tissue culture systems, gene analysis systems, and others; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, data analysis software, and others. It also provides drug discovery and custom research services; clinical diagnostics; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production. In addition, the company manufactures cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement kits, staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves educational institutions, research organizations, and companies engaged in biological science. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Tokyo, Japan.